Dr. John Lewis, professor at the University of Alberta, and his team at the Alberta Prostate Cancer Research Initiative (APCaRI) developed a machine learning analysis platform that uses patient biomarkers and clinical data to create predictive models and generate a risk score for accurate disease prediction. Dr. Lewis aims to improve disease prediction in patients at risk for prostate cancer, bladder cancer, and other diseases.

Dr. Gabriela Ilie, associate professor at Dalhousie University, and her colleagues Rob Rutledge and Ellen Sweeney examined the association between depression and anxiety and prostate cancer.

• Using data from 6,585 Atlantic PATH participants, they found that prostate cancer survivors had greater odds of screening positive for anxiety or depression.
• They also found that the association between depression, anxiety and prostate cancer is moderated by household income.
• Most recently, they found that prostate cancer survivors who were treated with surgery had 7.55 statistically significantly higher odds of screening positive for current depression compared to those who had surgery for other types of cancer.

Researchers at Atlantic PATH also found that toenails are useful biomarkers to investigate chronic inorganic arsenic exposure’s health impacts in prostate cancer cases. In Canada, inorganic arsenic exposure’s primary source is contaminated drinking water. Arsenic regulation in private well water is not government-regulated, and testing responsibility falls to homeowners. However, compliance is low and previous studies have shown that many wells in Atlantic Canada exceed the Health Canada Maximum Acceptable Concentration limit. Arsenic exposure can also occur because of occupational exposure, including welding, farming, glass manufacturing, construction, mining, and electronic/e-waste recycling.

Check out their latest webinars on various topics around prostate cancer, such as its impact on sexuality, sexual dysfunction, physical activity, and more!

This brochure describes the prostate-specific antigen (PSA) test for prostate cancer screening.

These videos explain the diagnosis, possible treatment options, and side effects for those diagnosed with localized prostate cancer or advanced prostate cancer.

To find prostate cancer-related services in your area, use their community services locator.

Movember offers resources dedicated to mental health, including a new tool to assist in having conversations with those who may be struggling with mental health and prostate cancer.

Prostate Cancer Support Canada offers a variety of virtual events and in-person events across the country. Check out their support group meeting and event calendar. Special events include group fitness classes, cancer-safe yoga, and peer networking.

Visit the Canadian Cancer Society Community Services Locator. This tool has filters set for prostate cancer and mental health services, including counselling, emotional support, and advocacy groups.

This fact sheet from the Canadian Centre for Occupational Health and Safety outlines different carcinogen exposures and their associations with certain types of cancer, particularly arsenic in the rubber production industry for prostate cancer.

This article from the Canadian Cancer Society describes changes you may experience with leaving and/or returning to work with prostate cancer and how to cope with these changes.